A Short Review on the Synthesis of 3,9-Disubstituted β-Carbolines: Unveiling Potent Anticancer and Antibacterial Properties

References

1. SinghD. VignatJ. LorenzoniV. EslahiM. GinsburgO. Lauby-SecretanB. ArbynM. BasuP. BrayF. VaccarellaS. Global estimates of incidence and mortality of cervical cancer in 2020: A baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.Lancet Glob. Health2023112e197e20610.1016/S2214‑109X(22)00501‑0 36528031
   [Google Scholar]
2. ChhikaraB.S. ParangK. Global Cancer Statistics 2022: The trends projection analysis.Chem. Biol. Lett.2023101451
   [Google Scholar]
3. MatthewsH.K. BertoliC. de BruinR.A.M. Cell cycle control in cancer.Nat. Rev. Mol. Cell Biol.2022231748810.1038/s41580‑021‑00404‑3 34508254
   [Google Scholar]
4. SungH. FerlayJ. SiegelR.L. LaversanneM. SoerjomataramI. JemalA. BrayF. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202171320924910.3322/caac.21660 33538338
   [Google Scholar]
5. EalaM.A.B. RobredoJ.P.G. DeeE.C. LinV. LagmayA.M.F.A. Climate crisis and cancer: Perspectives from the hardest hit.Lancet Oncol.2022233e9210.1016/S1470‑2045(21)00595‑7 35240093
   [Google Scholar]
6. Manzari-TavakoliA. BabajaniA. TavakoliM.M. SafaeinejadF. JafariA. Integrating natural compounds and nanoparticle‐based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy.Cancer Med.2024135e701010.1002/cam4.7010 38491817
   [Google Scholar]
7. MuhammadN. UsmaniD. TariqueM. NazH. AshrafM. RaliyaR. TabrezS. ZughaibiT.A. AlsaieediA. HakeemI.J. SuhailM. The role of natural products and their multitargeted approach to treat solid cancer.Cells20221114220910.3390/cells11142209 35883653
   [Google Scholar]
8. CraggG.M. PezzutoJ.M. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents.Med. Princ. Pract.201625Suppl. 2415910.1159/000443404 26679767
   [Google Scholar]
9. NajmiA. JavedS.A. Al BrattyM. AlhazmiH.A. Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents.Molecules202227234910.3390/molecules27020349 35056662
   [Google Scholar]
10. MarkmanM. MekhailT.M. Paclitaxel in cancer therapy.Expert Opin. Pharmacother.20023675576610.1517/14656566.3.6.755 12036415
    [Google Scholar]
11. TshikhudoP.P. MabhaudhiT. KoorbanallyN.A. MudauF.N. Avendaño CaceresE.O. PopaD. CalinaD. Sharifi-RadJ. Anticancer potential of β‐Carboline alkaloids: An updated mechanistic overview.Chem. Biodivers.2024212e20230126310.1002/cbdv.202301263 38108650
    [Google Scholar]
12. CaoR. PengW. WangZ. XuA. β-Carboline alkaloids: Biochemical and pharmacological functions.Curr. Med. Chem.200714447950010.2174/092986707779940998 17305548
    [Google Scholar]
13. ZhaoC. TaoM. XuL. FanN. ShuY. XiaoZ. WangZ. Silica-based nanodelivery systems loaded with matrine for the brown planthopper green control and rice growth promotion.ACS Sustain. Chem. Eng.20231149172991730910.1021/acssuschemeng.3c04570
    [Google Scholar]
14. AroraP. AroraV. LambaH.S. WadhwaD. Importance of heterocyclic chemistry: A review.Int. J. Pharm. Sci. Res.20123929472954
    [Google Scholar]
15. DzoboK. The role of natural products as sources of therapeutic agents for innovative drug discovery.Comprehensive Pharmacol202240842210.1016/B978‑0‑12‑820472‑6.00041‑4
    [Google Scholar]
16. DaiJ. DanW. SchneiderU. WangJ. β-Carboline alkaloid monomers and dimers: Occurrence, structural diversity, and biological activities.Eur. J. Med. Chem.201815762265610.1016/j.ejmech.2018.08.027 30125723
    [Google Scholar]
17. ZulkifliS.Z. PungotN.H. SaaidinA.S. JaniN.A. MohammatM.F. Synthesis and diverse biological activities of substituted indole β-carbolines: A review.Nat. Prod. Res.202438213793380610.1080/14786419.2023.2261141 37770197
    [Google Scholar]
18. Sharifi-RadJ. OzleyenA. Boyunegmez TumerT. Oluwaseun AdetunjiC. El OmariN. BalahbibA. TaheriY. BouyahyaA. MartorellM. MartinsN. ChoW.C. Natural products and synthetic analogs as a source of antitumor drugs.Biomolecules201991167910.3390/biom9110679 31683894
    [Google Scholar]
19. SerdaroğluG. ElikM. A computational study predicting the chemical reactivity behavior of 1-substituted 9-ethyl-βCCM derivatives: DFT-based quantum chemical descriptors.TCTC.20182111
    [Google Scholar]
20. LiY. LiuY. ZhuZ. YanW. ZhangC. YangZ. BaiP. TangM. ShiM. HeW. FuS. LiuJ. HanK. LiJ. XieL. YeH. YangJ. ChenL. Structure-based design and synthesis of N-substituted 3-Amino-β-Carboline derivatives as potent αβ-tubulin degradation agents.J. Med. Chem.20226532675269310.1021/acs.jmedchem.1c02159 35084853
    [Google Scholar]
21. Eftekhari-SisB. ZirakM. Chemistry of α-oxoesters: A powerful tool for the synthesis of heterocycles.Chem. Rev.2015115115126410.1021/cr5004216 25423283
    [Google Scholar]
22. KokelA. SchäferC. TörökB. Application of microwave-assisted heterogeneous catalysis in sustainable synthesis design.Green Chem.201719163729375110.1039/C7GC01393K
    [Google Scholar]
23. BeatoA. GoriA. BoucherleB. PeuchmaurM. HaudecoeurR. β-Carboline as a privileged scaffold for multitarget strategies in Alzheimer’s disease therapy.J. Med. Chem.20216431392142210.1021/acs.jmedchem.0c01887 33528252
    [Google Scholar]
24. AaghazS. SharmaK. JainR. KamalA. β-Carbolines as potential anticancer agents.Eur. J. Med. Chem.202121611332110.1016/j.ejmech.2021.113321 33684825
    [Google Scholar]
25. KumarS. SinghA. KumarK. KumarV. Recent insights into synthetic β -carbolines with anti-cancer activities.Eur. J. Med. Chem.2017142487310.1016/j.ejmech.2017.05.059 28583770
    [Google Scholar]
26. GirigoswamiK. PallaviP. GirigoswamiA. Intricate subcellular journey of nanoparticles to the enigmatic domains of endoplasmic reticulum.Drug Deliv.2023301228468410.1080/10717544.2023.2284684 37990530
    [Google Scholar]
27. CaoR. ChenQ. HouX. ChenH. GuanH. MaY. PengW. XuA. Synthesis, acute toxicities, and antitumor effects of novel 9-substituted β-carboline derivatives.Bioorg. Med. Chem.200412174613462310.1016/j.bmc.2004.06.038 15358288
    [Google Scholar]
28. PuJ. ChenB. WuW. YangC. ZhangG. ChrumaJ.J. Design and synthesis of fluorescent 1,3-Diaryl-β-carbolines and 1,3-Diaryl-3,4-dihydro-β-carbolines.ACS Omega2021618122381224910.1021/acsomega.1c01116 34250327
    [Google Scholar]
29. FoleyD.W. BermudezI. BaileyP.D. MeredithD. A cyclosporine derivative is a substrate of the oligopeptide transporter PepT1.MedChemComm201675999100210.1039/C5MD00575B
    [Google Scholar]
30. CaoR. ChenH. PengW. MaY. HouX. GuanH. LiuX. XuA. Design, synthesis and in vitro and in vivo antitumor activities of novel β-carboline derivatives.Eur. J. Med. Chem.20054010991100110.1016/j.ejmech.2005.04.008 15950325
    [Google Scholar]
31. CainM. WeberR.W. GuzmanF. CookJ.M. BarkerS.A. RiceK.C. CrawleyJ.N. PaulS.M. SkolnickP. beta.-Carbolines: Synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors.J. Med. Chem.19822591081109110.1021/jm00351a015 6127411
    [Google Scholar]
32. ZhangJ. LiL. DanW. LiJ. ZhangQ. BaiH. WangJ. Synthesis and antimicrobial activities of 3-Methyl-β-Carboline derivatives.Nat. Prod. Commun.2015106899902 26197512
    [Google Scholar]
33. ChenY.F. LinY.C. ChenJ.P. ChanH.C. HsuM.H. LinH.Y. KuoS.C. HuangL.J. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.Bioorg. Med. Chem. Lett.201525183873387710.1016/j.bmcl.2015.07.058 26235951
    [Google Scholar]
34. YinW. MajumderS. ClaytonT. PetrouS. VanLinnM.L. NamjoshiO.A. MaC. CromerB.A. RothB.L. PlattD.M. CookJ.M. Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.Bioorg. Med. Chem.201018217548756410.1016/j.bmc.2010.08.049 20888240
    [Google Scholar]
35. SahooC.R. PaidesettyS.K. PadhyR.N. Norharmane as a potential chemical entity for development of anticancer drugs.Eur. J. Med. Chem.201916275276410.1016/j.ejmech.2018.11.024 30496990
    [Google Scholar]
36. GuH. LiN. DaiJ. XiY. WangS. WangJ. Synthesis and in vitro antitumor activity of novel bivalent β-carboline-3-carboxylic acid derivatives with DNA as a potential target.Int. J. Mol. Sci.20181910317910.3390/ijms19103179 30326662
    [Google Scholar]
37. ChandraprasadM.S. DeyA. SwamyM.K. Introduction to cancer and treatment approaches. Paclitaxel.Cambridge, MassachusettsAcademic Press2022127
    [Google Scholar]
38. KhanS. ImranM. ButtT.T. Ali ShahS.W. SohailM. MalikA. DasS. ThuH.E. AdamA. HussainZ. Curcumin based nanomedicines as efficient nanoplatform for treatment of cancer: New developments in reversing cancer drug resistance, rapid internalization, and improved anticancer efficacy.Trends Food Sci. Technol.20188082210.1016/j.tifs.2018.07.026
    [Google Scholar]
39. AhmedS.A. MendoncaP. ElhagR. SolimanK.F.A. Anticancer effects of fucoxanthin through cell cycle arrest, apoptosis induction, angiogenesis inhibition, and autophagy modulation.Int. J. Mol. Sci.202223241609110.3390/ijms232416091 36555740
    [Google Scholar]
40. CooperG.S. YuanZ. StangeK.C. DennisL.K. AminiS.B. RimmA.A. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.Med. Care200038441142110.1097/00005650‑200004000‑00008 10752973
    [Google Scholar]
41. Mota-RojasD. Villanueva-GarcíaD. Mota-ReyesA. OrihuelaA. Hernández-ÁvalosI. Domínguez-OlivaA. Casas-AlvaradoA. Flores-PadillaK. Jacome-RomeroJ. Martínez-BurnesJ. Meconium aspiration syndrome in animal models: Inflammatory process, apoptosis, and surfactant inactivation.Animals20221223331010.3390/ani12233310 36496831
    [Google Scholar]
42. KoehnF.E. CarterG.T. The evolving role of natural products in drug discovery.Nat. Rev. Drug Discov.20054320622010.1038/nrd1657 15729362
    [Google Scholar]
43. MishraB.B. TiwariV.K. Natural products: An evolving role in future drug discovery.Eur. J. Med. Chem.201146104769480710.1016/j.ejmech.2011.07.057 21889825
    [Google Scholar]
44. NewmanD.J. CraggG.M. Natural products as sources of new drugs from 1981 to 2014.J. Nat. Prod.201679362966110.1021/acs.jnatprod.5b01055 26852623
    [Google Scholar]
45. ZaniC.P. ZaniA.P. ThomaziniC.M. RetamiroK.M. de OliveiraA.R. GonçalvesD.L. SarragiottoM.H. GarciaF.P. de OliveiraS.S. NakamuraC.V. Ueda-NakamuraT. β-Carboline-α-aminophosphonate derivative: A promising antitumor agent for breast cancer treatment.Molecules2023289394910.3390/molecules28093949 37175359
    [Google Scholar]
46. RichterM.F. HergenrotherP.J. The challenge of converting Gram‐positive‐only compounds into broad‐spectrum antibiotics.Ann. N. Y. Acad. Sci.201914351183810.1111/nyas.13598 29446459
    [Google Scholar]
47. KannanR. AnilA. ThomasP. SamuelR.N. RejiS.M. MathewA.A. Antibiotic susceptibility profiling of gram-positive and gram-negative bacterial isolates in a tertiary care hospital: Establishment of an antibiogram.Cureus2024165e6054210.7759/cureus.60542 38887355
    [Google Scholar]